ArticleJournal of neuromuscular diseases2026

Large-scale proteomics profiling of peripheral blood of DM1 patients identifies biomarkers for disease severity and functional capacity.

Daniël van As et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.